Evidence map›Paper›PMID 24887092›Full record

ArticlePloS one2014

Trajectories in glycemic control over time are associated with cognitive performance in elderly subjects with type 2 diabetes.

Ramit Ravona-Springer, Anthony Heymann, James Schmeidler, Erin Moshier, James Godbold, Mary Sano, Derek Leroith, Sterling Johnson, Rachel Preiss, Keren Koifman and 3 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Longitudinal trends in HbADiabetes/metabolism research and reviews · 2018
    Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Randomized Clinical Trial Examining the Impact ofNeuropsychiatric disease and treatment · 2020
    Article
  17. Article
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ramit Ravona-SpringerMemory clinic, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Anthony HeymannDepartment of Family Medicine, University of Tel Aviv, Tel Aviv, Israel.
James SchmeidlerDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, United States of America.
Erin MoshierDepartment of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, United States of America.
James GodboldDepartment of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, United States of America.
Mary SanoDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, United States of America.
Derek LeroithDepartment of Medicine, Icahn School of Medicine at Mount Sinai, New York, United States of America.
Sterling JohnsonGeriatric Research Education and Clinical Center, Madison VA Hospital and Alzheimer's Disease Research Center, Department of Medicine, University of Wisconsin, WI, United States of America.
Rachel PreissMaccabi Health Services, Tel Aviv, Israel.
Keren KoifmanMemory clinic, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Hadas HoffmanMaccabi Health Services, Tel Aviv, Israel.
Jeremy M SilvermanDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, United States of America.
Michal Schnaider BeeriDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, United States of America; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel.

Funding

QUANTITATIVE ANALYSIS OF MICROVASCULAR CHANGES IN THE AGING BRAINP01AG002219 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI HAROUTUNIAN, VAHRAM · 1985 to 2009
$19.2M
Inflammation, long-term diabetes characteristics, and cognitive declineR01AG034087 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SCHNAIDER BEERI, MICHAL · 2009 to 2014
$3.7M
NIA NIH HHS NIA-AG02219NIA NIH HHS P01 AG002219NIA NIH HHS P01-AG02219NIA NIH HHS R01 AG034087
6 · The paper itself

Abstract

objectiveTo study the relationships of long-term trajectories of glycemic control with cognitive performance in cognitively normal elderly with type 2 diabetes (T2D).

methodsSubjects (n = 835) pertain to a diabetes registry (DR) established in 1998 with an average of 18 HbA1c measurements per subject, permitting identification of distinctive trajectory groups of HbA1c and examining their association with cognitive function in five domains: episodic memory, semantic categorization, attention/working memory, executive function, and overall cognition. Analyses of covariance compared cognitive function among the trajectory groups adjusting for sociodemographic, cardiovascular, diabetes-related covariates and depression.

resultsSubjects averaged 72.8 years of age. Six trajectories of HbA1c were identified, characterized by HbA1c level at entry into the DR (Higher/Lower), and trend over time (Stable/Decreasing/Increasing). Both groups with a trajectory of decreasing HbA1c levels had high HbA1c levels at entry into the DR (9.2%, 10.7%), and high, though decreasing, HbA1c levels over time. They had the worst cognitive performance, particularly in overall cognition (p<0.02) and semantic categorization (p<0.01), followed by that of subjects whose HbA1c at entry into the DR was relatively high (7.2%, 7.8%) and increased over time. Subjects with stable HbA1c over time had the lowest HbA1c levels at entry (6.0%, 6.8%) and performed best in cognitive tests.

conclusionGlycemic control trajectories, which better reflect chronicity of T2D than a single HbA1c measurement, predict cognitive performance. A trajectory of stable HbA1c levels over time is associated with better cognitive function.

Indexed as

CognitionAgedDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansIsraelMaleRegistriesTime FactorsGlycated Hemoglobin

Identifiers

PMID24887092
PMCPMC4041655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.